Summit Therapeutics Inc. is a biotech company developing new medicines.
Summit Therapeutics Inc. (SMMT) is expected to report earnings on Monday, October 19, 2026, after the close. Estimated release time 16:07 ET. Consensus EPS estimate is $-0.28.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-02-23 | FY2025 Q4 | $-0.10 | $-0.29 | -182.5% | $0 |
| 2025-08-11 | FY2025 Q2 | $-0.09 | $-0.31 | -241.4% | $0 |
| 2025-05-01 | FY2025 Q1 | $-0.09 | $-0.07 | +29.0% | $0 |
| 2025-02-24 | FY2024 Q4 | $-0.08 | $-0.07 | +19.0% | $0 |
| 2024-10-30 | FY2024 Q3 | $-0.07 | $-0.06 | +17.3% | $0 |
| 2024-08-06 | FY2024 Q2 | $-0.06 | $-0.07 | -12.5% | $0 |
| 2024-05-01 | FY2024 Q1 | $-0.06 | $-0.05 | +18.2% | $0 |
| 2024-02-20 | FY2023 Q4 | — | $-0.04 | — | $0 |
SMMT has beaten consensus EPS in 4 of its last 8 reported quarters.
See SMMT on the live calendar →